Results 171 to 180 of about 19,553 (185)
Some of the next articles are maybe not open access.

Nanobodies in therapeutic applications.

Current opinion in molecular therapeutics, 2007
Over the years, many antibodies have been successfully generated to treat patients with life-threatening diseases, most notably cancer. While the first generation of antibodies, originating from mice, caused severe side effects and were relatively inefficient, technological advances have made it possible to obtain fully human antibodies for therapeutic
Roovers, Rob C.   +2 more
openaire   +3 more sources

Nanobodies: Natural Single-Domain Antibodies

Annual Review of Biochemistry, 2013
Sera of camelids contain both conventional heterotetrameric antibodies and unique functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric antibodies consists of one antigen-binding domain, the VHH, and two constant domains.
openaire   +3 more sources

Nanobody exchange chromatography

2021
The present invention relates to the field of affinity purification and provides for means and methods applying protein binding agents competing for a target protein for use as capture and elution tool, wherein the elution agent comprises an immunoglobulin single variable domain (ISVD), and is capable of displacing the capturing binding agent.
Steyaert, Jan   +6 more
openaire   +2 more sources

Nanobodies

RCSB Protein Data Bank, 2011
openaire   +2 more sources

Nanobody-functionalized polymersomes

Journal of Controlled Release, 2015
Tao, Zou   +5 more
openaire   +2 more sources

Anti-vcam-1 nanobodies

2016
The present invention relates to nanobodies specifically directed against VCAM-1 and to the use thereof in medical imaging and in diagnostic, prognostic and treatment methods.
Ghezzi, Catherine   +5 more
openaire   +2 more sources

Nanobody

2021
openaire   +1 more source

Nanobodies

Scientific American, 2005
openaire   +2 more sources

Home - About - Disclaimer - Privacy